Biomarkers of COVID-19 Severity Long Haul: An Examination of Genetic Variance of SARS-Cov-1 and SARS-Cov-2 and Treatment Options a Meta-Analysis and Systematic Review
Year: 2025
Type: review
Abstract: This meta-analysis and systematic review article will provide the findings of the “All of Us” research meta-analysis, which aims to evaluate emerging biomarkers linked to severe COVID-19 and data analysis of 50 peer-reviewed journals for PUBMED, Walden University research library, Web of Science, and Scopus databases. What role each SARS- virus genetic makeup play in disease severity when compared to cases and their The COVID-19 pandemic has underscored the necessity for reliable biomarkers to predict disease severity and patient outcomes compare SARS-cov-1.
Author: Kawana Jeffer Williams
Institution: Walden University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4409143017